Cart summary

You have no items in your shopping cart.

INY-03-041

INY-03-041

Catalog Number: orb1992823

DispatchUsually dispatched within 5-10 working days
Contact us for a quotation
Catalog Numberorb1992823
CategorySmall Molecules
DescriptionINY-03-041, a potent and highly selective PROTAC-based pan-AKT degrader, inhibits AKT1, AKT2, and AKT3 with IC50s of 2.0 nM, 6.8 nM, and 3.5 nM, respectively. This compound consists of the ATP-competitive AKT inhibitor GDC-0068 conjugated to Lenalidomide.
Purity98.00%
MW798.41
SMILESO=C(C(N(CC1=C2C=CC=C1CCCCCCCCCCNC[C@H](C3=CC=C(Cl)C=C3)C(N4CCN(C5=C([C@H](C)C[C@H]6O)C6=NC=N5)CC4)=O)C2=O)CC7)NC7=O
FormulaC44H56ClN7O5
Biological ActivityINY-03-041, a potent and highly selective PROTAC-based pan-AKT degrader, inhibits AKT1, AKT2, and AKT3 with IC50s of 2.0 nM, 6.8 nM, and 3.5 nM, respectively. This compound consists of the ATP-competitive AKT inhibitor GDC-0068 conjugated to Lenalidomide.
Storage-20°C
NoteFor research use only
Expiration Date12 months from date of receipt.
  • INY-03-041 trihydrochloride [orb1983287]

    98.00%

    907.8

    C44H59Cl4N7O5

    50 mg, 5 mg
  • 9-Decyn-1-ol [orb1909241]

    98.00%

    17643-36-6

    154.25

    C10H18O

    500 mg, 100 mg
  • Lenalidomide-C9-aldehyde [orb1988267]

    98.00%

    398.5

    C23H30N2O4

    500 mg, 100 mg
  • Ipatasertib-NH2 [orb1988275]

    98.00%

    1001382-14-4

    415.92

    C21H26ClN5O2

    500 mg, 100 mg